Yuzhen Yin
Overview
Explore the profile of Yuzhen Yin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
196
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Du Y, Ouyang B, Liu Y, Yin Y, Wu Y, Guo H
Curr Pharm Des
. 2025 Jan;
PMID: 39819416
Background: Nitric oxide (NO) is a low-toxicity and high-efficiency anticancer treatment that can augment the cytotoxicity of doxorubicin (DOX) towards breast cancer cells, thereby exhibiting a favorable effect on chemotherapy...
2.
Yang M, Liu H, Lou J, Zhang J, Zuo C, Zhu M, et al.
Small
. 2023 Oct;
20(9):e2307448.
PMID: 37845027
Radium-223 ( Ra) is the first-in-class alpha-emitter to mediate tumor eradication, which is commonly thought to kill tumor cells by directly cleaving double-strand DNA. However, the immunogenic characteristics and cell...
3.
Qin S, Yang Y, Zhang J, Yin Y, Liu W, Zhang H, et al.
Mol Pharm
. 2023 Oct;
20(11):5543-5553.
PMID: 37788300
Small cell lung cancer (SCLC) is a neuroendocrine tumor with a high degree of malignancy. Due to limited treatment options, patients with SCLC have a poor prognosis. We have found,...
4.
Wei F, Yin Y, Li J, Chang Y, Zhang S, Zhao W, et al.
J Ethnopharmacol
. 2023 Sep;
319(Pt 1):117169.
PMID: 37704119
Ethnopharmacological Relevance: Pulmonary injury and fibrosis can be caused by various factors because of their inflammatory nature, both can lead to serious clinical consequences. Inula japonica Thunb. is used in...
5.
Zhu M, Zhang J, Yang M, Zhang H, Xu T, Kan F, et al.
J Cancer Res Clin Oncol
. 2023 Apr;
149(11):8429-8442.
PMID: 37085729
Purpose: Nanobodies have become promising carriers due to excellent in vivo properties. Radiopharmaceutical therapy targeting programmed cell death ligand 1 (PD-L1) is an effective therapeutic strategy. Our study aimed to...
6.
Yang J, Yang H, Cao L, Yin Y, Shen Y, Zhu W
Medicine (Baltimore)
. 2023 Jan;
101(49):e31799.
PMID: 36626437
Background: Experiments have shown that metformin can inhibit cancer cell growth, but clinical observations have been inconsistent, so we pooled the currently available data to evaluate the impact of metformin...
7.
Huang Y, Zhang H, Fan X, Wang J, Yin Y, Zhang Y, et al.
J Cardiovasc Transl Res
. 2022 Oct;
16(3):581-589.
PMID: 36251229
Changes in the intestinal flora and its metabolites have been associated with cardiovascular disease (CVD). Short-chain fatty acids, bile acids, and especially trimethylamine N-oxide (TMAO), an endothelial toxic factor produced...
8.
Zhang X, Zhang H, Zhang J, Yang M, Zhu M, Yin Y, et al.
Immunology
. 2022 Oct;
168(3):375-388.
PMID: 36217274
The cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathway is an essential component of the innate immune system and is central to the identification of abnormal DNA leakage caused by...
9.
Zhang J, Li F, Yin Y, Liu N, Zhu M, Zhang H, et al.
Biomater Res
. 2022 Sep;
26(1):44.
PMID: 36076298
Background: Astatine-211 is an α-emitter with high-energy α-ray and high cytotoxicity for cancer cells. However, the targeted alpha therapy (TAT) also suffers from insufficient systematic immune activation, resulting in tumor...
10.
Yin Y, Zhang P, He L, Guo X, Wang H, Li J, et al.
Evid Based Complement Alternat Med
. 2022 Aug;
2022:1227308.
PMID: 36034960
Anti-CD19 chimeric antigen receptor (CAR) T-cells are an effective treatment for refractory B-cell lymphoma, but CD19 deletion is prone to relapse. We conducted this study to find more effective dual...